Phase II Trial for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) Treated With Gliadel Followed by Concurrent Radiation Therapy, Temodar and Avastin, Then Followed by Avastin and Temodar Post-Radiation.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary) ; Bevacizumab; Temozolomide
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 27 Jan 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2018.
- 16 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jan 2017.
- 20 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016, as reported by ClinicalTrials.gov.